Artwork

内容由Rare in Common and Cambridge BioMarketing提供。所有播客内容(包括剧集、图形和播客描述)均由 Rare in Common and Cambridge BioMarketing 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Episode 21 – From broad questions to exact answers

19:50
 
分享
 

Manage episode 413262843 series 2136231
内容由Rare in Common and Cambridge BioMarketing提供。所有播客内容(包括剧集、图形和播客描述)均由 Rare in Common and Cambridge BioMarketing 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
With gene therapies on the horizon, a diagnosis is more important than ever. In this installment of the American College of Medical Genetics and Genomics (ACMG) series, our guest Melanie O’Leary discusses the Rare Genomes Project and the goal to use whole genome sequencing technology to find answers for those with undiagnosed genetic diseases. Listen as she explains why broad is better in finding a diagnosis and the importance of partnerships with patients.
  continue reading

29集单集

Artwork
icon分享
 
Manage episode 413262843 series 2136231
内容由Rare in Common and Cambridge BioMarketing提供。所有播客内容(包括剧集、图形和播客描述)均由 Rare in Common and Cambridge BioMarketing 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
With gene therapies on the horizon, a diagnosis is more important than ever. In this installment of the American College of Medical Genetics and Genomics (ACMG) series, our guest Melanie O’Leary discusses the Rare Genomes Project and the goal to use whole genome sequencing technology to find answers for those with undiagnosed genetic diseases. Listen as she explains why broad is better in finding a diagnosis and the importance of partnerships with patients.
  continue reading

29集单集

كل الحلقات

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

边探索边听这个节目
播放